{
  "url": "https://openlegislation.uk/eu-regulation-2012-722/annex-I/division-1/division-1.2/division-1.2.1",
  "json_url": "https://openlegislation.uk/eu-regulation-2012-722/annex-I/division-1/division-1.2/division-1.2.1.json",
  "legislation": "eur/2012/722",
  "legislation_title": "Commission Regulation (EU) No 722/2012 of 8 August 2012 concerning particular requirements as regards the requirements laid down in Council Directives 90/385/EEC and 93/42/EEC with respect to active implantable medical devices and medical devices manufactured utilising tissues of animal origin (Text with EEA relevance)",
  "legislation_url": "https://openlegislation.uk/eu-regulation-2012-722",
  "path": "annex/I/division/1/division/1.2/division/1.2.1",
  "kind": "division",
  "number": "1.2.1",
  "heading": "Animals as a source of material",
  "text": "The TSE risk is related to the source species, strains and nature of the starting tissue. As the accumulation of TSE infectivity occurs over an incubation period of several years, sourcing from young healthy animals is considered to be a factor reducing the risk. Risk animals such as fallen stock, emergency slaughtered and TSE suspected animals must be excluded as a source of material.",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eur/2012/722/annex/I/division/1/division/1.2/division/1.2.1",
    "retrieved_at": "2026-11-01T14:49:16.665664+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}